DKSH provides cold chain logistical support to BaiyaPhytopharm for the research and development of the first plant-based COVID-19 vaccine in Thailand
Bangkok, November 7, 2022 – DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, has provided logistical support to BaiyaPhytopharm, a clinical-stage biopharmaceutical company, focused on strengthening health security for all people using the BaiyaPharming protein for therapeutics and vaccines.
Since 2021, DKSH has provided logistical support to BaiyaPhytopharm by transporting the Intermediate Crude Extract (ICE) of tobacco leaves from BaiyaPhytopharm’s laboratory to the Kingen Biotech and Queen Saovabha Memorial Institutes for vaccine production. DKSH’s cold chain solution has been instrumental in fulfilling the critical temperature control requirements of two to eight degrees Celsius during transit to preserve the quality of the vaccines.
Dr. Suthira Taychakhoonavudh, CEO and Co-founder of BaiyaPhytopharm, said “We are currently in the second generation of research and development for plant-based COVID-19 vaccines, which have demonstrated high protective efficacy against the COVID-19 virus and the capacity to deal with various types of mutated viruses. However, the research and development of vaccines require strict temperature control to preserve vaccine efficacy. We are confident that DKSH's expertise and uniqueness in cold chain management will maintain the quality of our vaccine throughout all stages of our research, and that we will be able to deliver the COVID-19 vaccine to Thai people in the near future."
Patrik Grande, Vice President, Business Unit Healthcare, DKSH Thailand, commented: “We are proud to support the Thai research organization in its efforts to develop locally manufactured COVID-19 vaccines. DKSH has the capabilities and expertise to manage the storage and distribution of vaccines, cold chain products, medicines, and medical devices. Coupled with our experience in the continuous distribution of vaccines in Thailand, we are ready to provide BaiyaPhytopharm logistical support throughout the research and development of COVID-19 vaccines. We look forward to taking part in the delivery of COVID-19 vaccines to Thai people, allowing them access to locally manufactured vaccines and elevating the pharmaceutical industry in Thailand, which reflects the DKSH's core purpose of enriching people's lives."
About BaiyaPhytopharm
BaiyaPhytopharm, is a clinical-stage biopharmaceutical company focused on strengthening health security for all people using the BaiyaPharmingTM platform. The platform has the flexibility to produce biopharmaceutical products of interest within weeks rather than months or years resulting in faster and lower cost research and development.
Our team combines deep technical expertise in plant biotech, pharmaceutical production and clinical development capabilities to create biologic candidates with high unmet medical need in the ASIA-Pacific region. We have generated a broad proprietary portfolio of candidates including monoclonal antibody for cancer or infectious disease and new vaccines for neglected tropical diseases. For more information, please visit https://baiyaphytopharm.com/
About DKSH
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 33,100 specialists, generating net sales of CHF 11.1 billion in 2021. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With around 7,920 specialists, the Business Unit generated net sales of CHF 5.6 billion in 2021. www.dksh.com/hec